Risk of major bleeding during extended oral anticoagulation in patients with first unprovoked venous thromboembolism: a systematic review and meta-analysis protocol

BACKGROUND: The optimal duration of anticoagulation after a first unprovoked venous thromboembolism (VTE) remains controversial. Deciding to stop or continue anticoagulant therapy indefinitely after completing 3 to 6 months of initial treatment requires balancing the long-term risk of recurrent VTE...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Syst Rev
Autors principals: Khan, Faizan, Kimpton, Miriam, Tritschler, Tobias, Le Gal, Grégoire, Hutton, Brian, Fergusson, Dean A., Rodger, Marc A.
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2019
Matèries:
Protocol
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6819358/
https://ncbi.nlm.nih.gov/pubmed/31661033
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13643-019-1175-5
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars